21 – 30 of 148
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson’s disease symptom tracking and patients’ and care partners’ communications with the treating healthcare professional : the SELF-AWARE study
- Contribution to journal › Article
-
Mark
Multiple System Atrophy Without Dysautonomia : An Autopsy-Confirmed Study
- Contribution to journal › Article
-
Mark
Navigating the therapeutic landscape in advanced Parkinson’s disease : a comprehensive review from infusion therapies to stem cells
- Contribution to journal › Scientific review
-
Mark
Far from being the end of the road : taking a closer look at neuropalliative care in Parkinson’s disease
- Contribution to journal › Scientific review
-
Mark
Infusion therapies for Parkinson’s disease : where are we in 2025?
(2025) In Expert Opinion on Drug Delivery
- Contribution to journal › Article
- 2024
-
Mark
Pain Fluctuations in Parkinson's Disease and Their Association with Motor and Non-Motor Fluctuations
- Contribution to journal › Article
-
Mark
Monotherapy with infusion therapies – useful or not?
- Contribution to journal › Scientific review
-
Mark
Patients’ Perspective in Hereditary Ataxia
- Contribution to journal › Article
-
Mark
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
- Contribution to journal › Article
-
Mark
EEG Frequency Correlates with α2-Receptor Density in Parkinson’s Disease
- Contribution to journal › Article
